Homecare support to improve adherence in multiple sclerosis
Author:
- 1 October 2011
- journal article
- Published by Mark Allen Group in British Journal of Neuroscience Nursing
- Vol. 7 (5) , 655-659
Abstract
There are approximately 100 000 people in the UK who have been diagnosed with multiple sclerosis (MS). Long-term adherence by patients to the widely used treatment disease modifying therapies (DMTs) can be a challenge. The aim of this survey was to understand the critical points of contact where homecare support could impact adherence and provide suggestions to improve the homecare support services provided to MS patients. Homecare support is defined as any sponsored patient support programme from a homecare company. Surveys were sent to 5 025 MS patients and 150 MS nurses working within the NHS. Completed survey responses were obtained from 1 868 MS patients (37%) and 42 MS nurses (28%). Patients and specialist nurses reported that training and support in the early stages of treatment could influence adherence, particularly when that training is tailored specifically to the patients’ requirements and unlimited by time and resources.Keywords
This publication has 4 references indexed in Scilit:
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosisEuropean Journal of Neurology, 2010
- Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort studyMultiple Sclerosis Journal, 2010
- Impact of Adherence to Interferons in the Treatment of Multiple SclerosisClinical Drug Investigation, 2010
- Factors that influence adherence with disease-modifying therapy in MSJournal of Neurology, 2009